Shares of Global Medical REIT Inc (NYSE:GMRE) have earned an average rating of “Buy” from the seven ratings firms that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $13.63.
Several analysts recently issued reports on GMRE shares. Janney Montgomery Scott upgraded shares of Global Medical REIT from a “neutral” rating to a “buy” rating and set a $14.50 price target on the stock in a research report on Tuesday, January 7th. Stifel Nicolaus increased their price target on shares of Global Medical REIT from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Tuesday, December 17th. B. Riley raised their target price on Global Medical REIT from $13.00 to $15.00 and gave the company a “buy” rating in a report on Friday, December 20th. TheStreet raised Global Medical REIT from a “c+” rating to a “b-” rating in a report on Monday, October 14th. Finally, Zacks Investment Research downgraded Global Medical REIT from a “buy” rating to a “hold” rating in a report on Saturday, November 9th.
Shares of GMRE traded up $0.07 during trading hours on Thursday, hitting $14.80. 830,438 shares of the company were exchanged, compared to its average volume of 413,960. The company has a market cap of $543.13 million, a price-to-earnings ratio of 19.64 and a beta of 0.44. Global Medical REIT has a fifty-two week low of $9.36 and a fifty-two week high of $14.93. The company has a quick ratio of 0.13, a current ratio of 0.13 and a debt-to-equity ratio of 1.25. The firm’s fifty day moving average is $13.42 and its 200 day moving average is $11.85.
The business also recently declared a quarterly dividend, which was paid on Thursday, January 9th. Stockholders of record on Thursday, December 26th were paid a $0.20 dividend. The ex-dividend date was Tuesday, December 24th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 5.41%. Global Medical REIT’s payout ratio is currently 102.56%.
Several institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. boosted its holdings in shares of Global Medical REIT by 68.8% during the 2nd quarter. BlackRock Inc. now owns 2,225,649 shares of the company’s stock valued at $23,368,000 after acquiring an additional 907,360 shares in the last quarter. Foundry Partners LLC acquired a new stake in Global Medical REIT during the 3rd quarter worth approximately $5,186,000. Nuveen Asset Management LLC acquired a new stake in Global Medical REIT during the 2nd quarter worth approximately $4,171,000. Vanguard Group Inc. lifted its holdings in shares of Global Medical REIT by 22.7% during the second quarter. Vanguard Group Inc. now owns 1,974,041 shares of the company’s stock worth $20,727,000 after purchasing an additional 364,967 shares during the period. Finally, United Services Automobile Association lifted its holdings in shares of Global Medical REIT by 98.9% during the second quarter. United Services Automobile Association now owns 260,646 shares of the company’s stock worth $2,737,000 after purchasing an additional 129,600 shares during the period. Institutional investors own 48.71% of the company’s stock.
Global Medical REIT Company Profile
Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Featured Article: Why is the ex-dividend date different from the record date?
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.